MedPath

Master Study for the Investigation of Safety and Efficacy of the EVIA Pacemaker

Not Applicable
Completed
Conditions
Pacemaker Indication
Interventions
Device: EVIA Pacemaker
Registration Number
NCT00916344
Lead Sponsor
Biotronik SE & Co. KG
Brief Summary

The objective of this study is to prove the safety and efficacy of the EVIA pacemaker. Primarily, the newly implemented Atrial Capture Control algorithm is evaluated, which automatically measures the right atrial threshold and subsequently adjusts the pacing output.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
175
Inclusion Criteria
  • Meet the indications for pacemaker therapy
  • Understand the nature of the procedure
  • Give informed consent
  • Able to complete all testing required by the clinical protocol
  • Available for follow-up visits on a regular basis at the investigational site
Exclusion Criteria
  • Meet none of the pacemaker indications
  • Meet one or more of the contraindications
  • Patients with chronic atrial fibrillation (dual chamber pacemaker only)
  • Have a life expectancy of less than six months
  • Cardiac surgery in the next six months
  • Enrolled in another cardiac clinical investigation
  • Have other medical devices that may interact with the implanted pacemaker

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Pacemaker therapyEVIA Pacemaker-
Primary Outcome Measures
NameTimeMethod
Efficacy of Atrial Capture Control Feature (Automatic Atrial Threshold Test Minus Manual Atrial Measurement)1 month follow-up completed

atrial capture control: feature that automatically measures the atrial pacing threshold and subsequently adjusts the atrial pulse amplitude.

atrial threshold test: measurable automatically or manually.

Secondary Outcome Measures
NameTimeMethod
Complication Free Rate1- and 3- month follow-up completed

Complication free rate (in %):

1 minus(the number of possibly pacemaker related complications divided by the number of patients)

Trial Locations

Locations (1)

CHU Bordeaux Haut-Lévêque

🇫🇷

Pessac, Bordeaux, France

© Copyright 2025. All Rights Reserved by MedPath